On May 3, 2022, PRIM&R hosted a webinar, Un-Common Rules: Navigating FDA-Regulated Research and the IRB. During the webinar, Belinda…
Read More
This is part two of a two-part post on the ethical and practical considerations of risk in AI research. Read…
Read More
This is part one of a two-part post on the ethical and practical considerations of risk in AI research. Read…
Read More
In recognition of Pride Month, we'd like to highlight some resources—both from PRIM&R and from other organizations—that explore the importance…
Read More
Diversity, equity, and inclusion have become a focal point since the COVID-19 pandemic exposed the disproportionate —and systemically ingrained— health…
Read More